Chantix concerns
The FDA has issued an Early Communication About an Ongoing Safety Review
Varenicline (marketed as Chantix).
News and recovery-oriented commentary about current controversies, emerging trends and research findings related to drug and alcohol addiction, treatment and recovery.
The FDA has issued an Early Communication About an Ongoing Safety Review
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home